Strong Profits, Stronger Stocks: Andhra Sugars and Entero Healthcare Deliver Double-Digit Market Gains

Nikunj Parikh - Mumbai Bureau Aug 10, 2026 1,900 Views

Shares of Entero Healthcare Solutions rose 10% and Andhra Sugars surged 15.6% on August 10, 2026, following strong Q1 FY27 earnings. Entero reported a 37.27% net profit rise to ₹38.16 crore, while Andhra Sugars posted a 94.09% net profit increase to ₹45.61 crore.

MUMBAI — Shares of healthcare supply chain distributor Entero Healthcare Solutions Limited and diversified manufacturer The Andhra Sugars Limited surged during morning trading on Monday, August 10, 2026, following the release of their first-quarter (Q1 FY27) financial results. Entero Healthcare Solutions shares rallied 10% in early trade, while Andhra Sugars jumped 15.6% as equity investors responded to substantial net profit expansion and top-line growth disclosed in regulatory filings to domestic stock exchanges.

The sharp upward momentum across both counters underscores strong buying interest in healthcare distribution and industrial commodities amid the ongoing corporate earnings season.

Entero Healthcare Solutions Posts 37% Profit Surge

Entero Healthcare Solutions recorded a 10% gain in share price after reporting strong consolidated financial performance for the quarter ended June 30, 2026. According to official exchange filings, the company’s consolidated net profit for Q1 FY27 expanded by 37.27% year-on-year to ₹38.16 crore, up from ₹27.80 crore reported in the corresponding period of the previous fiscal year.

Consolidated revenue from sales rose 38.23% year-on-year to ₹1,940.50 crore compared to ₹1,403.82 crore in Q1 FY26. The company's operating profit margin (OPM) improved to 5.00%, driven by network expansion, improved scale in pharmaceutical distribution, and operational efficiencies across its logistics hubs.

Andhra Sugars Shares Surge 15.6% on 94% Profit Rise

The Andhra Sugars Limited saw its stock jump 15.6% after publishing strong earnings performance for the June 2026 quarter. Exchange submissions show that the company’s consolidated net profit nearly doubled, surging 94.09% year-on-year to ₹45.61 crore for Q1 FY27, compared to ₹23.50 crore in Q1 FY26.

Revenue from operations grew 4.55% year-on-year to ₹627.11 crore from ₹599.79 crore in the year-ago period. Profit margins were bolstered by improved realizations in key business segments, including industrial chemicals, sugar, and caustic soda operations, alongside lower raw material cost overheads.

Official Sources Section

Financial disclosures, revenue figures, and trading statistics cited in this article are derived directly from official regulatory reports:

National Stock Exchange of India (NSE India)
: Official price feeds and corporate result disclosures under SEBI LODR Regulations.
Bombay Stock Exchange (BSE India)
: Quarterly financial results and regulatory announcements.

Quote Section

According to official stock exchange filings and earnings releases:

"Market operational desks recorded significant buying activity in Entero Healthcare Solutions and Andhra Sugars following the announcement of Q1 FY27 financial results. Quarterly profit growth and improved operating margins served as primary drivers for early trading gains."

Why It Matters

The strong earnings performance and subsequent stock gains carry practical implications for market participants:

Healthcare Distribution Momentum: Entero Healthcare’s revenue growth highlights sustained institutional and retail demand across India's pharmaceutical supply chain network.
Industrial and Sugar Realizations: Andhra Sugars' margin expansion points to favorable operating conditions across chemical and agricultural processing industries.
Investor Sentiment: Positive earnings surprises continue to attract targeted capital inflows into mid-cap and small-cap growth counters.

Key Facts at a Glance

Entero Healthcare: Shares rose 10% as Q1 net profit grew 37.27% to ₹38.16 crore.
Entero Revenue: Q1 sales increased 38.23% year-on-year to ₹1,940.50 crore.
Andhra Sugars: Shares jumped 15.6% after Q1 net profit surged 94.09% to ₹45.61 crore.
Andhra Sugars Revenue: Consolidated quarterly sales rose 4.55% to ₹627.11 crore.

Frequently Asked Questions (FAQ)

Q1: Why did Entero Healthcare Solutions shares rise on August 10, 2026?

Entero Healthcare shares rose 10% after reporting a 37.27% increase in Q1 FY27 consolidated net profit to ₹38.16 crore and a 38.23% jump in revenue to ₹1,940.50 crore.

Q2: What was the main reason for Andhra Sugars' stock surge?

Andhra Sugars' stock surged 15.6% following a 94.09% year-on-year increase in Q1 FY27 net profit to ₹45.61 crore, supported by margin expansion across its business divisions.

Q3: Where can investors verify official quarterly earnings filings for these companies?

Investors can view verified financial disclosures on the official portals of the National Stock Exchange of India (NSE) and the Bombay Stock Exchange (BSE).